Concert Pharmaceuticals, Inc. Net Profit Margin 2014-2022 | CNCE
Concert Pharmaceuticals, Inc. net profit margin from 2014 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2022-09-30 |
$0.00B |
$-0.13B |
inf% |
2022-06-30 |
$0.00B |
$-0.13B |
-12500.00% |
2021-12-31 |
$0.03B |
$-0.08B |
-245.45% |
2021-09-30 |
$0.03B |
$-0.07B |
-203.03% |
2021-06-30 |
$0.03B |
$-0.06B |
-173.53% |
2021-03-31 |
$0.01B |
$-0.08B |
-962.50% |
2020-12-31 |
$0.01B |
$-0.07B |
-925.00% |
2020-09-30 |
$0.01B |
$-0.07B |
-900.00% |
2020-06-30 |
$0.01B |
$-0.07B |
-1166.67% |
2020-03-31 |
$0.00B |
$-0.08B |
inf% |
2019-12-31 |
$0.00B |
$-0.08B |
-7800.00% |
2019-09-30 |
$0.00B |
$-0.08B |
-7900.00% |
2019-06-30 |
$0.00B |
$-0.08B |
-7900.00% |
2019-03-31 |
$0.00B |
$-0.07B |
-7300.00% |
2018-12-31 |
$0.01B |
$-0.06B |
-550.00% |
2018-09-30 |
$0.01B |
$-0.04B |
-400.00% |
2018-06-30 |
$0.15B |
$0.10B |
67.53% |
2018-03-31 |
$0.15B |
$0.10B |
67.53% |
2017-12-31 |
$0.14B |
$0.10B |
65.97% |
2017-09-30 |
$0.14B |
$0.09B |
61.81% |
2017-06-30 |
$0.00B |
$-0.05B |
inf% |
2017-03-31 |
$0.00B |
$-0.05B |
inf% |
2016-12-31 |
$0.00B |
$-0.05B |
inf% |
2016-09-30 |
$0.01B |
$-0.04B |
-370.00% |
2016-06-30 |
$0.01B |
$-0.04B |
-291.67% |
2016-03-31 |
$0.07B |
$0.02B |
29.23% |
2015-12-31 |
$0.07B |
$0.02B |
36.36% |
2015-09-30 |
$0.06B |
$0.01B |
24.56% |
2015-06-30 |
$0.06B |
$0.02B |
25.42% |
2015-03-31 |
$0.01B |
$-0.03B |
-485.71% |
2014-12-31 |
$0.01B |
$-0.03B |
-400.00% |
2014-09-30 |
$0.01B |
$-0.02B |
-250.00% |
2014-06-30 |
$0.01B |
$-0.02B |
-380.00% |
2014-03-31 |
$0.02B |
$-0.01B |
-52.38% |
2013-12-31 |
$0.03B |
$-0.01B |
-24.00% |